Genesis Healthcare Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Genesis Healthcare's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2020 |
Recent past performance updates
Revenue & Expenses Breakdown
How Genesis Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 20 | 3,906 | -59 | 595 | 0 |
| 30 Sep 20 | 4,123 | -63 | 593 | 0 |
| 30 Jun 20 | 4,308 | 46 | 601 | 0 |
| 31 Mar 20 | 4,496 | 63 | 616 | 0 |
| 31 Dec 19 | 4,566 | 15 | 594 | 0 |
| 30 Sep 19 | 4,616 | -43 | 513 | 0 |
| 30 Jun 19 | 4,710 | -147 | 429 | 0 |
| 31 Mar 19 | 4,837 | -182 | 336 | 0 |
| 31 Dec 18 | 4,977 | -235 | 279 | 0 |
| 30 Sep 18 | 5,119 | -256 | 342 | 0 |
| 30 Jun 18 | 5,217 | -571 | 354 | 0 |
| 31 Mar 18 | 5,286 | -597 | 398 | 0 |
| 31 Dec 17 | 5,374 | -579 | 406 | 0 |
| 30 Sep 17 | 5,423 | -467 | 359 | 0 |
| 30 Jun 17 | 5,501 | -114 | 361 | 0 |
| 31 Mar 17 | 5,568 | -72 | 328 | 0 |
| 31 Dec 16 | 5,625 | -64 | 332 | 0 |
| 30 Sep 16 | 5,657 | -352 | 332 | 0 |
| 30 Jun 16 | 5,656 | -361 | 334 | 0 |
| 31 Mar 16 | 5,645 | -355 | 334 | 0 |
| 31 Dec 15 | 5,519 | -425 | 326 | 0 |
| 30 Sep 15 | 5,278 | -283 | 316 | 0 |
| 30 Jun 15 | 5,056 | -298 | 302 | 0 |
| 31 Mar 15 | 4,842 | -312 | 288 | 0 |
| 31 Dec 14 | 4,690 | -240 | 279 | 0 |
| 30 Sep 14 | 4,641 | -170 | 392 | 0 |
| 31 Dec 13 | 4,640 | -171 | 284 | 0 |
Quality Earnings: Insufficient data to determine if GENN has high quality earnings.
Growing Profit Margin: Insufficient data to determine if GENN's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if GENN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare GENN's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if GENN's earnings growth over the past year exceeded the Healthcare industry average.
Return on Equity
High ROE: GENN has a negative Return on Equity (0%), as it is currently unprofitable.